{"id":17474,"date":"2016-06-30T00:00:00","date_gmt":"2016-06-30T00:00:00","guid":{"rendered":"https:\/\/cadca1stg.wpengine.com\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/"},"modified":"2016-06-30T00:00:00","modified_gmt":"2016-06-30T00:00:00","slug":"dea-releases-2016-national-heroin-threat-assessment-summary","status":"publish","type":"resource","link":"https:\/\/www.cadca.org\/es\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","title":{"rendered":"La DEA publica el resumen de la evaluaci\u00f3n nacional de la amenaza de la hero\u00edna de 2016"},"content":{"rendered":"<p>La Administraci\u00f3n para el Control de Drogas (DEA) public\u00f3 el <a href=\"https:\/\/www.dea.gov\" target=\"_blank\" rel=\"noopener\">Resumen de la Evaluaci\u00f3n Nacional de la Amenaza de la Hero\u00edna de 2016<\/a> esta semana.<\/p>\n<p>Algunos datos clave son:<\/p>\n<ul>\n<li>El n\u00famero de personas que informaron sobre el consumo actual de hero\u00edna casi se triplic\u00f3 entre 2007 (161 000) y 2014 (435 000).\u00a0<\/li>\n<li>Las muertes por opi\u00e1ceos sint\u00e9ticos, como el fentanilo y sus an\u00e1logos, aumentaron un 79 % entre 2013 y 2014.<\/li>\n<li>Las muertes relacionadas con la hero\u00edna se triplicaron con creces entre 2010 (3036) y 2014 (10 574), una tasa m\u00e1s r\u00e1pida que otras drogas il\u00edcitas.<\/li>\n<\/ul>\n<p>Una novedad en el resumen de este a\u00f1o es la informaci\u00f3n sobre un fen\u00f3meno reciente, el fentanilo disfrazado de p\u00edldoras recetadas, algo supuestamente responsable de la muerte de 19 personas en Florida y California durante el primer trimestre de 2016. Motivados por el enorme potencial de ganancias, los traficantes est\u00e1n explotando la alta demanda de los consumidores. para analg\u00e9sicos, tranquilizantes y sedantes recetados il\u00edcitos mediante la producci\u00f3n de falsificaciones econ\u00f3micas que contienen fentanilo que se pueden vender en la calle.<\/p>\n<p>\u201cTendemos a abusar de palabras como &#039;sin precedentes&#039; y &#039;horrible&#039;, pero la muerte y la destrucci\u00f3n relacionadas con la hero\u00edna y los opi\u00e1ceos son, de hecho, horrendas y sin precedentes\u201d, dijo el administrador interino de la DEA, Chuck Rosenberg, en un comunicado de prensa. \u201cEl problema es enorme y est\u00e1 creciendo, y todos nuestros ciudadanos deben darse cuenta de estos hechos\u201d.<\/p>\n<p>El n\u00famero de usuarios, admisiones a tratamiento, muertes por sobredosis y decomisos de traficantes aumentaron con respecto a los informados en el resumen del a\u00f1o pasado. Adem\u00e1s, la hero\u00edna fue la mayor amenaza de las drogas informada por el 45 por ciento (frente al 38 por ciento del a\u00f1o pasado y al 7 por ciento, en comparaci\u00f3n, en 2007) de las agencias policiales estatales, locales y tribales que respondieron a la Encuesta Nacional de Amenazas de Drogas de 2016.<\/p>\n<p><strong>VER TAMBI\u00c9N:<\/strong><\/p>\n<p><a href=\"https:\/\/www.cadca.org\/es\/news\/cadca-joins-deas-comprehensive-strategy-address-heroin-opioid-abuse-and-violent-crime\/\" target=\"_blank\" rel=\"noopener\">CADCA se une a la estrategia integral de la DEA para abordar la hero\u00edna, el abuso de opioides y los delitos violentos<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number<\/p>","protected":false},"author":23,"featured_media":0,"template":"","resource_type":[281],"drug_specific_issues":[312],"action_to_do":[],"class_list":["post-17474","resource","type-resource","status-publish","hentry","resource_type-coalitions-online","drug_specific_issues-heroin"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cadca.org\/es\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA\" \/>\n<meta property=\"og:description\" content=\"The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cadca.org\/es\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/\" \/>\n<meta property=\"og:site_name\" content=\"CADCA\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\",\"name\":\"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\"},\"datePublished\":\"2016-06-30T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/resource\\\/dea-releases-2016-national-heroin-threat-assessment-summary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cadca.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DEA Releases 2016 National Heroin Threat Assessment Summary\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cadca.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cadca.org\\\/\",\"name\":\"CADCA\",\"description\":\"The Premier Prevention Association\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cadca.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cadca.org\/es\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","og_locale":"es_ES","og_type":"article","og_title":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","og_description":"The Drug Enforcement Administration (DEA) released the 2016\u00a0National Heroin Threat Assessment Summary this week. Some key facts are: The number","og_url":"https:\/\/www.cadca.org\/es\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","og_site_name":"CADCA","og_image":[{"width":880,"height":500,"url":"https:\/\/www.cadca.org\/wp-content\/uploads\/2022\/03\/cadca-member-of-logo1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","url":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/","name":"DEA Releases 2016 National Heroin Threat Assessment Summary | CADCA","isPartOf":{"@id":"https:\/\/www.cadca.org\/#website"},"datePublished":"2016-06-30T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cadca.org\/resource\/dea-releases-2016-national-heroin-threat-assessment-summary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cadca.org\/"},{"@type":"ListItem","position":2,"name":"DEA Releases 2016 National Heroin Threat Assessment Summary"}]},{"@type":"WebSite","@id":"https:\/\/www.cadca.org\/#website","url":"https:\/\/www.cadca.org\/","name":"CADCA","description":"The Premier Prevention Association","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cadca.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/17474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource"}],"about":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/types\/resource"}],"author":[{"embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/users\/23"}],"version-history":[{"count":0,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource\/17474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/media?parent=17474"}],"wp:term":[{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/resource_type?post=17474"},{"taxonomy":"drug_specific_issues","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/drug_specific_issues?post=17474"},{"taxonomy":"action_to_do","embeddable":true,"href":"https:\/\/www.cadca.org\/es\/wp-json\/wp\/v2\/action_to_do?post=17474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}